Glenmark cleared to market Nitrostat generic

MUMBAI, India — Glenmark Pharmaceuticals Inc. USA has received final approval from the Food and Drug Administration for nitroglycerin sublingual tablets in strengths of 0.3 mg, 0.4 mg and 0.6 mg. Glenmark said Wednesday that its nitroglycerin product, which is placed under the tongue, is a generic version of Nitrostat sublingual tablets (0.3 mg, 0.4